Potassium%2525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte replacement medication used to treat or prevent hypokalemia. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Prevention of hypokalemia:** 20 mEq (1.5 g) orally once daily. * **Treatment of hypokalemia:** Dosing varies significantly based on serum potassium levels and clinical status. * Mild hypokalemia (serum K 3.0-3.4 mEq/L): 40-60 mEq (3-4.5 g) orally per day, divided in 2-3 doses. * Moderate hypokalemia (serum K 2.5-2.9 mEq/L): 60-100 mEq (4.5-7.5 g) orally per day, divided in 3-4 doses. * Severe hypokalemia (serum K < 2.5 mEq/L) or symptomatic hypokalemia: Intravenous administration is typically required. Dosing protocols vary widely. A common initial approach for severe, symptomatic hypokalemia may involve administering 20-40 mEq (1.5-3 g) of potassium chloride intravenously over 1-2 hours, with repeat doses based on continuous ECG monitoring and serum potassium levels. **Maximum recommended IV infusion rate is typically 10-20 mEq/hour, and maximum concentration is usually 40 mEq/L (or 80 mEq/L in critical care settings with cardiac monitoring). Higher doses or rates may be associated with increased risk of cardiac arrhythmias.** ## Pediatric Dosing * **Prevention of hypokalemia:** 1-2 mEq/kg/day orally, divided into 1-2 doses. Maximum: 20 mEq/day. * **Treatment of hypokalemia:** Dosing varies based on serum potassium levels. * Oral: 2-4 mEq/kg/day divided into 2-4 doses. Maximum: 40 mEq/day. * Intravenous: Dosing protocols are highly variable and depend on serum potassium levels, age, and clinical condition. **Typical maintenance IV infusion rates for potassium are 20-40 mEq/L of IV fluid. For correction of hypokalemia, doses up to 0.5 mEq/kg infused over 1 hour may be used, with careful monitoring.** **Refer to specific pediatric protocols.** ## Dose Adjustments * **Renal Impairment:** Use with caution and reduced dosage. Monitor potassium levels closely. Contraindicated in severe renal impairment. ## Contraindications * Hyperkalemia. * Conditions which may predispose to hyperkalemia, such as chronic renal failure, untreated Addison's disease, acute dehydration, extensive tissue breakdown (e.g., severe burns, crush injuries), or the administration of potassium-sparing diuretics. * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, flatulence. Esophageal or gastrointestinal ulceration or bleeding can occur, particularly with oral solid dosage forms if not taken with sufficient fluid or if there is delayed gastric emptying. * **Cardiovascular:** Hyperkalemia, which can lead to cardiac arrhythmias, conduction abnormalities, and cardiac arrest. * **Other:** Hyperkalemia. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs:** Increased risk of hyperkalemia. * **NSAIDs:** May impair potassium excretion and increase risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase the risk of digoxin toxicity. Hypokalemia can increase the risk of digoxin toxicity. ## Monitoring * Serum potassium levels. * ECG (especially with IV administration or severe hypokalemia). * Renal function. * Signs and symptoms of hypokalemia and hyperkalemia. ## Clinical Pearls * Oral solid dosage forms should be taken with plenty of water to prevent gastrointestinal irritation and ulceration. * Liquid formulations are often preferred in pediatrics and for patients with swallowing difficulties. * Potassium chloride is generally considered the salt of choice for potassium replacement unless contraindicated. * Intravenous potassium chloride is a vesicant and should be administered cautiously and with appropriate dilution and infusion rates to avoid phlebitis and cardiac complications. * The maximum rate and concentration of IV potassium administration should follow institutional guidelines and be based on patient monitoring. *** *This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols for complete details and to verify dosages and safety information before administering any medication.*